Answers are grounded in this paper and cite their sources.
Adjunctive intracoronary administration of nicorandil, an ATP-sensitive potassium channel opener, after successful coronary revascularization was performed in a 54-year-old patient with acute myocardial infarction. The 'no-reflow' phenomenon disappeared after nicorandil administration and significant functional recovery of the infarcted myocardium was achieved. This suggests that nicorandil could eliminate the 'no-reflow' phenomenon after successful coronary revascularization.
No takes yet. Share an insight, caveat, or question.
Sakata et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: